Published : 19 May, 2026
In an article published by The Scientist, Dr Jaskaran Singh Sethi , Sr. Consultant & Chief of GI, GU, HPB, & TBI Radiation Oncology Services, RGCIRC discusses how human stem cell-derived organoids are transforming pancreatic cancer research. The study highlighted in the article demonstrates that organoid models can capture subtle genetic and epigenetic alterations associated with early pancreatic tumour development, which are often missed by conventional mouse models. Dr. [Surname] notes that these advanced laboratory models have the potential to accelerate drug discovery, improve understanding of tumour biology, and pave the way for more personalized treatment strategies for pancreatic cancer patients.
My Reports
RGCIRC, Niti Bagh
